SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BREVEGLIERI, Giulia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.385
AS - Asia 6.381
EU - Europa 4.262
SA - Sud America 1.016
Continente sconosciuto - Info sul continente non disponibili 303
AF - Africa 159
OC - Oceania 26
AN - Antartide 1
Totale 22.533
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.110
SG - Singapore 2.232
CN - Cina 1.869
IT - Italia 1.032
PL - Polonia 863
BR - Brasile 814
VN - Vietnam 673
DE - Germania 521
HK - Hong Kong 489
UA - Ucraina 441
GB - Regno Unito 329
TR - Turchia 268
FR - Francia 235
FI - Finlandia 215
SE - Svezia 206
JP - Giappone 161
BD - Bangladesh 139
CA - Canada 138
IN - India 137
RU - Federazione Russa 137
ID - Indonesia 102
MX - Messico 83
NL - Olanda 73
AR - Argentina 72
ZA - Sudafrica 52
IQ - Iraq 37
BE - Belgio 35
ES - Italia 35
IR - Iran 35
PK - Pakistan 35
EC - Ecuador 31
CO - Colombia 28
VE - Venezuela 28
UZ - Uzbekistan 25
MA - Marocco 23
MY - Malesia 22
KR - Corea 21
AU - Australia 20
LT - Lituania 20
CZ - Repubblica Ceca 19
PH - Filippine 18
TN - Tunisia 17
KE - Kenya 15
CH - Svizzera 14
EG - Egitto 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
CL - Cile 13
PT - Portogallo 11
PY - Paraguay 11
CR - Costa Rica 10
JM - Giamaica 10
PE - Perù 10
AT - Austria 9
AZ - Azerbaigian 9
DZ - Algeria 9
ET - Etiopia 9
RO - Romania 9
TW - Taiwan 9
IE - Irlanda 8
NP - Nepal 8
JO - Giordania 7
LV - Lettonia 7
BG - Bulgaria 6
GR - Grecia 6
KZ - Kazakistan 6
LB - Libano 6
PA - Panama 6
TH - Thailandia 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
HN - Honduras 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
SI - Slovenia 5
UY - Uruguay 5
BB - Barbados 4
GE - Georgia 4
IL - Israele 4
NI - Nicaragua 4
PS - Palestinian Territory 4
RS - Serbia 4
YE - Yemen 4
EE - Estonia 3
HU - Ungheria 3
KW - Kuwait 3
NG - Nigeria 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
BO - Bolivia 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
LY - Libia 2
ML - Mali 2
SV - El Salvador 2
Totale 22.198
Salva come PNG Salva come JPEG
Città #
Singapore 1.406
Ashburn 1.214
Warsaw 849
San Jose 776
Beijing 705
Woodbridge 699
Fairfield 559
Chandler 557
Houston 498
Ann Arbor 492
Jacksonville 486
Hong Kong 475
Santa Clara 449
Ferrara 294
Wilmington 275
Seattle 242
Ho Chi Minh City 226
Dallas 224
New York 207
Council Bluffs 198
Nanjing 184
Los Angeles 172
Cambridge 167
Hanoi 166
Tokyo 149
Izmir 146
Bologna 127
Princeton 116
Milan 110
Munich 109
Lauterbourg 102
Boardman 91
Addison 84
Shanghai 79
Jakarta 68
Helsinki 66
Orem 65
Shenyang 58
Bremen 55
San Diego 54
São Paulo 54
Mexico City 50
Redwood City 48
Nanchang 46
Brooklyn 44
London 42
Toronto 42
Turku 42
Chennai 40
Montreal 39
Da Nang 36
Denver 36
Falls Church 36
Rio de Janeiro 36
Hebei 35
Frankfurt am Main 33
Hefei 33
Buffalo 32
Haiphong 32
Moscow 32
Stockholm 32
Dearborn 31
Guangzhou 31
Brussels 30
Hangzhou 30
Chicago 29
Johannesburg 29
Zhengzhou 29
Changsha 28
Rome 28
Manchester 27
Tianjin 27
San Francisco 25
Auburn Hills 24
Jiaxing 23
Verona 23
Phoenix 22
Poplar 22
Tashkent 22
The Dalles 22
Mountain View 21
Atlanta 20
Brasília 20
Curitiba 20
Dong Ket 19
Guayaquil 19
Nuremberg 17
Amsterdam 16
Columbus 16
Norwalk 16
Baghdad 15
Belo Horizonte 15
Boston 15
Jinan 15
Ningbo 15
Mumbai 14
Orange 14
Sydney 14
Ankara 13
Brno 13
Totale 14.648
Salva come PNG Salva come JPEG
Nome #
A validated cellular biobank for β-thalassemia 419
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 418
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 381
Postnatal and non-invasive prenatal detection of β-thalassemia mutations based on Taqman genotyping assays 378
A validated THALAMOSS cellular biobank for β-thalassemia 342
Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin 309
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 301
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 301
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 282
Erythroid induction of K562 cells treated with mithramycin is associated with inhibition of raptor gene transcription and mammalian target of rapamycin complex 1 (mTORC1) functions 271
Y-chromosome identification in circulating cell-free fetal DNA using surface plasmon resonance 265
SPR-based non-invasive prenatal testing for fetal sex determination 264
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 253
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 250
A novel and efficient protocol for Surface Plasmon Resonance based detection of four β-thalassemia point mutations in blood samples and salivary swabs 244
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 237
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 234
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 230
Surface plasmon resonance analysis to detect the β+ IVSI-110 thalassemia mutation in circulating cell-free fetal DNA 228
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 227
SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome 227
Droplet Digital PCR for Non-Invasive Prenatal Detection of Fetal Single-Gene Point Mutations in Maternal Plasma 227
Therapy for Cystic Fibrosis Caused by Nonsense Mutations 224
Peptide nucleic acids targeting β-globin mRNAs selectively inhibit hemoglobin production in murine erythroleukemia cells 220
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 218
High levels of apoptosis induced in human glioma cell lines by combined treatment with antagomiR PNAs and pre-miRNA molecules 218
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 217
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 215
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 212
Constitutive systemic inflammation in Shwachman-Diamond Syndrome 204
Detection of the sickle hemoglobin allele using a surface plasmon resonance based biosensor 202
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 200
Effect of bioencapsulation on the secretomic profile o fIB3-1 cystic fibrosis cells 196
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 195
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 194
Non-invasive fetal sex diagnosis in plasma of early weeks pregnants using droplet digital PCR 194
Development and characterization of K562 cell clones expressing at high levels BCL11A: induction of erythroid differentiation by mithramycin 193
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 191
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 190
Cellular biosensors for the identification of fetal hemoglobin inducers 189
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 189
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 189
Alteration of microRNA biological activity with peptide nucleic acid 188
Biological evaluation of psoralen derivatives as inhibitors of NF-κB/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 188
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 185
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 183
Development and molecular characterization of transgenic mice for beta-thalassemia 180
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 178
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 176
Detection methods for the identification of Alicyclobacillus species involved in food spoilage 174
Modulation of the Biological Activity of microRNA-210 with Peptide Nucleic Acids (PNAs) 168
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 167
IL-17 family members exert an autocrine pro-inflammatory loop in CF respiratory epithelial cells ex vivo 163
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 163
Gene therapy combined with HbF induction in beta-thalassemia 163
Gene therapy and fetal hemoglobin induction 159
Targeting the miR-221/miR-222 cluster in cancer therapy 158
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 157
Uptake by human glioma cell lines and biological effects of a peptide-nucleic acids targeting miR-221. 157
In vitro induction of interleukin-8 by SARS-CoV-2 Spike protein is inhibited in bronchial epithelial IB3-1 cells by a miR-93-5p agomiR 156
Non-invasive prenatal detection of beta-thalassemia mutations in maternal plasma using Droplet Digital PCR 153
A Signature of Differentially Expressed Micrornas in Lymphoblastoid Cells from Shwachman-Diamond Syndrome Patients Indicates Possible Molecular Targets for Mirna Therapeutics 153
Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells 151
Evidences for miRNA regulation of BCL11A gene expression 150
Peptide nucleic acids targeting miR-221 in human breast cancer: uptake and modulation of miR-221 biological functions. 149
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of β°39 thalassemia mutation 148
TNF-alpha induced release of IL-8 by IB3-1 cells encapsulated in alginate microbeads 148
Non-invasive Prenatal Testing Using Fetal DNA 146
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 145
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 143
Up-regulation of miR-34a-3p and miR-744-3p is associated with down-regulation of PTEN in lymphoblastoid cells from Shwachman-Diamond Syndrome patients 141
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 137
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 137
Set up of a NK cell-sensitive tumour model in C57BL/6 mice 135
Detection of genomic disorders in unamplified human genomic DNA using an ultrasensitive surface plasmon resonance imaging method 135
Peptide nucleic acids targeting miR-221 in breast cancer cell lines: uptake and modulation of miR-221 and p27kip1 biological function 134
Surface Plasmon Resonance Imaging (SPR-I), peptide nucleic acid (PNA) probes and nanoparticle-enhancement for PCR-free ultrasensitive detection of beta-thalassemia mutations in human genomic DNA 132
Inhibition of micro RNA 210 biological activity with an anti-miR-210 peptide nucleic acid 132
MTOR and STAT3 pathway hyper-activation is associated with elevated interleukin-6 levels in patients with shwachman-diamond syndrome: Further evidence of lymphoid lineage impairment 132
Detection of disorders in unamplified human genomic DNA 132
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 132
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 130
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 129
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 129
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 129
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 129
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 127
PNA-mediated alteration of mRNA splicing 126
Induction of high levels of apoptosis of temozolomide-resistant T98G glioma cells by co-administration of peptide nucleic acids targeting miR-221 and miR-222 123
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 123
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 120
SPR-based identification of microRNAs 118
Production of a cellular model for the screening of inducers of fetal haemoglobin 117
null 117
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 117
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 116
Secretome Release During In Vitro Bone Marrow-Derived Mesenchymal Stem Cell Differentiation Induced by Bio-Oss® Collagen Material 115
Molecular regulation of the expression of AbetaHJ-J locus, encoding Aspartyl-beta-hydroxylase, Junctin and Junctate 114
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 114
UPF1 silenced cellular model systems for screening of read-through agents active on β039 thalassemia point mutation 114
Totale 18.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.038
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.809
Totale 98.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.084 0 103 33 40 85 70 60 48 51 110 104 380
2022/20231.278 137 124 25 161 224 167 74 116 130 10 52 58
2023/2024808 50 107 35 31 64 156 82 42 11 16 52 162
2024/20252.965 80 70 230 154 305 246 127 144 511 327 391 380
2025/20268.495 818 318 670 1.012 1.252 562 1.020 534 789 970 370 180
2026/2027577 312 265 0 0 0 0 0 0 0 0 0 0
Totale 22.533